The Net Margin of CymaBay Therapeutics Inc (CBAY) is -339.10%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2023-12-31 | -339.10% |
| 2022-12-31 | -275.60% |